Outcome of HLA-oriented therapy for gastric cancer in retrospective and prospective study.
Author:
Affiliation:
1. Department of Gastrointestinal Surgery, Tokai University
2. Department of Surgery, Tokyo Medical University
3. Department of Transplantation Immunology, Tokai University
4. Department of Surgery, Chiba University
Publisher
The Japanese Society of Strategies for Cancer Research and Therapy
Subject
Pharmacology (medical),Cancer Research,Oncology
Link
https://www.jstage.jst.go.jp/article/acrt/16/2/16_2_36/_pdf
Reference31 articles.
1. 1)Ludwig, J.A., Weinstein, J.N. (2005) Biomarkers in cancer staging, prognosis and treatment selection Nat Rev. Cancer 5: 845-856.
2. 2)Chen, H-Y., Yu, S-L., Chen, C-H., Chang, G-C., Chen, C-Y., Yuan, A., Cheng, C-L., Wang, C-H., Terng, H-J., Kao, S-F., Chan, W-K., Li, H-N., Liu, C-C., Singh, S., Chen, W.J., Chen, J.J.W., Yang, P-C. (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med. 356: 11-20.
3. 3)Endoh, H., Tomida, S., Yatabe, Y., Konishi, H., Osada, H., Tajima, K., Kuwano, H., Takahashi, T., Mitsudomi, T. (2004) Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J. Clin. Oncol. 22: 811-819.
4. 4)Potti, A., Dressman, H.K., Bild, A., Riedel, R.F., Chan, G., Sayer, R., Cragun, J. Cottrill, H., Kelley, M.J., Petersen, R., Harpole, D., Marks, J., Berchuck, A., Ginsburg, G.S., Febbo, P., Lancaster. J., Nevins, J.R. (2006) Genomic signatures to guide the use of chemotherapeutics. Nat. Med. 12: 1294-1300.
5. 5)Benacerraf, B., McDevitt, H.O. (1972) Histocompatibility-linked immune response genes. Science 175: 273-279.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effective and ineffective personalized therapy based on serum HLA from a 30-year odyssey;Annals of Cancer Research and Therapy;2011
2. HLA-B54 is a candidate of response to Fluoropyrimidine plus PSK therapy in gastric cancer;Annals of Cancer Research and Therapy;2009
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3